Clinical Trials on Non-Small Cell Lung Cancer, Ovarian Cancer

Total 16735 results

ZhuGuangYing
Zhejiang Cancer Hospital; 307 Hospital of PLA; Fudan University; Cancer Institute... and other collaborators

Unknown

Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Telik

Completed

TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States
AstraZeneca

Completed

A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer

Non-small-cell Lung Cancer

United Kingdom
Eli Lilly and Company

Completed

A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Mexico, Italy, Australia, Spain
Eli Lilly and Company

Completed

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Belgium
University Hospital, Antwerp
Sanofi; Universiteit Antwerpen

Completed

Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer (TOLEDO)

Non-small Cell Lung Cancer

Belgium
Eli Lilly and Company

Completed

Chemotherapy for Patients With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Taiwan
Eli Lilly and Company

Completed

Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients

Non Small Cell Lung Cancer

France
Ascenta Therapeutics

Completed

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Russian Federation, United States, Ukraine
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
Istituto Clinico Humanitas

Unknown

Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Italy
Asan Medical Center
Boryung Pharmaceutical Co., Ltd

Unknown

FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
AstraZeneca

Completed

A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

Non-small Cell Lung Cancer

China
Eli Lilly and Company
Bristol-Myers Squibb

Completed

Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States
Tragara Pharmaceuticals, Inc.

Completed

Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients

Non-small Cell Lung Cancer

United States
Chinese Academy of Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing... and other collaborators

Unknown

Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Symphony Evolution, Inc.

Terminated

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Non-Small-Cell Lung Cancer

United States
The First Affiliated Hospital of Guangzhou Medical...

Unknown

Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Sanofi

Terminated

Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
The First Affiliated Hospital of Guangzhou Medical...

Unknown

Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer (VATS)

Non-small Cell Lung Cancer

China
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
Sanofi

Completed

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Non-small Cell Lung Cancer

Italy
Rigshospitalet, Denmark

Terminated

Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

Non-small Cell Lung Cancer

Denmark
The First Affiliated Hospital of Guangzhou Medical...

Unknown

Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Eli Lilly and Company

Terminated

Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer

Non-Small-Cell Lung Cancer

Spain
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
Tokyo University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Japan
National Cancer Institute (NCI)

Completed

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer

United States
Alaunos Therapeutics

Unknown

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Cancer | Small Cell Lung Cancer | Ovarian Cancer | Thymoma | Osteosarcoma | Non Small Cell Lung Cancer | Malignancy | Testicular Cancer

United States
Liaoning Tumor Hospital & Institute

Not yet recruiting

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Non Small Cell Lung Cancer
Guangzhou University of Traditional Chinese Medicine
Akeso Pharmaceuticals, Inc.

Recruiting

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

Non-small Cell Lung Cancer

China
Dizal Pharmaceuticals

Recruiting

DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)

Non-small Cell Lung Cancer

China
Fondazione Policlinico Universitario Campus Bio-Medico
IRCCS San Raffaele; A.O.U. Città della Salute e della Scienza - Molinette Hospital

Recruiting

A Study to Investigate the Family History of Cancer in Patients With Non-small Cell Lung Cancer (FAHIC - Lung). (FAHIC-Lung)

Non Small Cell Lung Cancer

Italy
AbbVie

Recruiting

A Study to Assess Prevalence of a Specific Protein Overexpression in Adult Participants With Non-Small Cell Lung Cancer (METRIX)

Non Small Cell Lung Cancer

Canada, United Kingdom
Second Affiliated Hospital of Guangzhou Medical...

Not yet recruiting

Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Universitair Ziekenhuis Brussel

Recruiting

Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients (MAGMA)

Non-small Cell Lung Cancer

Belgium
Shanghai Kechow Pharma, Inc.

Not yet recruiting

Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study

Non-small-cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.

Non-small Cell Lung Cancer

China
BeiGene

Recruiting

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Qianfoshan Hospital

Recruiting

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial (FTANLCNDG)

Non-Small-Cell Lung Cancer

China
Royal College of Surgeons, Ireland

Recruiting

PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study (PLAN)

Non-small Cell Lung Cancer

Ireland
Chipscreen Biosciences, Ltd.

Recruiting

A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC

Non Small Cell Lung Cancer

China
Xinqiao Hospital of Chongqing

Recruiting

An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment

Non Small Cell Lung Cancer

China
Guangdong Association of Clinical Trials

Recruiting

Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD

Non Small Cell Lung Cancer

China
Yonsei University

Not yet recruiting

An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to Sotorasib (breakthrough)

Non Small Cell Lung Cancer

Korea, Republic of
Tang-Du Hospital

Recruiting

Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIIA-IIIB Resectable NSCLC (FORESEE)

Non-small Cell Lung Cancer

China
Karen Reckamp, MD, MS
Enviro Therapeutics, Inc.

Recruiting

Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

Lung Cancer | Non Small Cell Lung Cancer

United States
Peking University Cancer Hospital & Institute

Recruiting

A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Henan Cancer Hospital

Recruiting

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China

3

Subscribe